CompletedNot applicableNCT01935752
Pathophysiological Mechanisms of Fibromuscular Dysplasia
Studying Fibromuscular dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Michel Azizi, MD, PhD., PAHEGP, APHP, Paris, France
- Intervention
- blood samples(other)
- Enrollment
- 150 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2011 – 2014
Study locations (1)
- Cic9201, Hegp, Aphp,, Paris, France
Collaborators
Fondation pour la Recherche Médicale
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01935752 on ClinicalTrials.govOther trials for Fibromuscular dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT04804683European/International FMD Registry and InitiativeCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGNCT04906356Canadian SCAD StudyCardiology Research UBC
- RECRUITINGNCT01967511Defining the Basis of Fibromuscular Dysplasia (FMD)Icahn School of Medicine at Mount Sinai